Non-Invasive Glucose Monitoring Devices Market size was valued at USD 15 million in 2021 and expected to reach USD 94.1 million by 2028 growing at a CAGR of 30% during the forecast period 2022 to 2028. Non-Invasive Glucose Monitoring Devices Market has many market players and highly fragmented. Market players investing on product innovations to sustain their position in the market. In addition collaborations and acquisitions are key strategies used by market players to increase their market share. For example in 2014, NovioSense had created smaller than usual electrochemical sensor that empower non-obtrusive glucose checking and is equipped for identifying glucose focus in human tears. Technological progressions and expanding FDA endorsement for observing gadgets is required to give lucrative development chances to showcase players in coming years. For example, advancement of new checking gadgets, for example, GlucoTrack which is a non-obtrusive blood glucose screen that clasps to ear cartilage consequently disposing of the requirement for day by day finger pricks.Systemic Lupus Erythematosus (SLE) is an immune system infection that influences different organ frameworks of the body, and its side effects go from general disquietude to genuine, CNS and renal indications. Presently, there are restricted treatment choices accessible to treat the condition. Corticosteroids, hydroxychloroquine, and ordinary immunosuppressant are the pillar of treatment for SLE. Non-Invasive Blood Glucose Monitoring Devices use a painless approach to track a patient’s glucose level on a continuous basis. Non-invasive blood glucose monitoring devices require fewer finger sticks and allow data to be easily transferred and shared for further analysis. Patients can use these gadgets at home to monitor their blood glucose levels. Noninvasive glucose monitoring reduces the necessity for unpleasant pricking, which increases the risk of infection and the amount of damage to finger tissue.